WHO, FAO and OIE launches second round of results of AMR country self-assessment survey. Status of countries regarding the actions taken to implement the global action plan to address antimicrobial resistance is now available in an open access global tripartite database. All responses to the country self-assessment questionnaire sent out in 2016 and 2017 can be found in the database with answers visualized through maps and in table form. This year, WHO, FAO and OIE have also published an analysis report of the country responses.
The new WHO recommendations aim to help preserve the effectiveness of antibiotics that are important for human medicine by reducing their unnecessary use in animals. “A lack of effective antibiotics is as serious as a security threat as a sudden and deadly disease outbreak”, says Dr Tedros Adhanom Ghebreyesus, Director-General of WHO.
Call for comments on a target product profile (TPP) for a semi-open multiplex multi-analyte diagnostic platform
DEADLINE: 22 December 2017 The World Health Organization is partnering with Médecins Sans Frontières (MSF) and the Foundation for Innovative New Diagnostics (FIND) to develop a target product profile (TPP) for a semi-open multiplex multi-analyte diagnostic platform. This platform will help better diagnose the millions of people presenting with severe febrile illness without a known source in low- and middle-income countries.
19 September 2017 - A new WHO report finds that very few antibiotics currently in development address the serious and growing threat of antimicrobial resistance. The report shows a lack of potential treatment options for drug-resistant tuberculosis and 12 other classes of priority pathogens identified by WHO. Tuberculosis is responsible for about 250 000 deaths a year and some of the other pathogens, such as GRAM-negatives, can kill patients in just a few days due to the lack of treatment options.
Informal Member State Consultation on the Global Framework for Development and Stewardship to Combat Antimicrobial Resistance
9-10 November 2017
Location: Geneva, Switzerland
Member State Meeting participants can sign up until 20 October 2017
7 July 2017 – Data from 77 countries show that antibiotic resistance is making gonorrhoea – a common sexually-transmitted infection – more difficult, and sometimes impossible, to treat. Some countries – particularly high-income ones, where surveillance is best – are finding cases of the infection that are untreatable by all known antibiotics. These cases may just be the tip of the iceberg, as gonorrhoea is more common in lower-income countries.
Antimicrobial resistance (AMR) is the ability of a microorganism (like bacteria, viruses, and some parasites) to stop an antimicrobial (such as antibiotics, antivirals and antimalarials) from working against it. As a result, standard treatments become ineffective, infections persist and may spread to others.
About antimicrobial resistance (AMR)
- Fact sheet on antimicrobial resistance
- Fact sheet on antibiotic resistance
- Questions and answers on AMR
- 10 Facts on antimicrobial resistance
- Q&A: Why is vaccination important for addressing antibiotic resistance?
- Q&A: What is multidrug-resistant tuberculosis?
Global action plan (GAP) on antimicrobial resistance
Implementation of the global action plan
- Awareness and education
- Surveillance of antimicrobial resistance
- Infection prevention and control
- Optimal use of antimicrobial medicines in human and animal health
- R&D and investment
National action plans
Monitoring and Evaluation
News and media
Why talking about sex is good for your health
UN announces interagency group to coordinate global fight against antimicrobial resistance
WHO stresses urgent need for R&D for drug-resistant TB alongside newly-prioritized antibiotic-resistant pathogens
WHO publishes list of bacteria for which new antibiotics are urgently needed
WHO recommends 29 ways to stop surgical infections and avoid superbugs
Resources and publications
- Tripartite Monitoring and Evaluation (M&E) framework for the Global Action Plan on Antimicrobial Resistance
- Turning plans into action for antimicrobial resistance (AMR) : Working Paper 2.0: Implementation and coordination
- Assessing entry points and options for increasing investments in AMR in low- and middle-income countries: country case studies
- Tackling antimicrobial resistance together: Working paper 1.0: Multisectoral working
- WHO list of critically important antimicrobials for human medicine (CIA list) - 2017
Join our online Community of Practice
Are you developing/implementing a national action plan to address antimicrobial resistance? Would you welcome an opportunity for informal peer-to-peer discussions and/or access to prompt technical advice for operational challenges? The Community of practice holds a library of resources, from many different stakeholders, on a range of topics relevant to national action plans
Resistance in disease and areas
Call for consultants/proposals
AMR in the WHO Regions
- Public consultation: Target product profiles to develop rapid low- cost test for gonorrhoea and chlamydia diagnosis and antibiotic resistance testing for gonorrhoea - deadline: 30 June 2019
- Informal Member State Consultation on the Global Framework for Development and Stewardship to Combat Antimicrobial Resistance
- Meeting on monitoring of antimicrobial resistance: outcome and goal indicators - 8-9 June 2017
- Meeting of the WHO AMR Surveillance and Quality Assessment Collaborating Centres Network - 13-14 December 2016
- 2nd Meeting of the Global Antimicrobial Resistance Surveillance System (GLASS) Collaborative Platform - 15-16 December 2016